These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 33251462)
1. Quercetin Covalently Linked Lipid Nanoparticles: Multifaceted Killing Effect on Tumor Cells. Chen SQ; Wang C; Song YQ; Tao S; Yu FY; Lou HY; Hu FQ; Yuan H ACS Omega; 2020 Nov; 5(46):30274-30281. PubMed ID: 33251462 [TBL] [Abstract][Full Text] [Related]
2. Rational Design of Redox-Responsive and P-gp-Inhibitory Lipid Nanoparticles with High Entrapment of Paclitaxel for Tumor Therapy. Chen SQ; Wang C; Tao S; Wang YX; Hu FQ; Yuan H Adv Healthc Mater; 2018 Sep; 7(17):e1800485. PubMed ID: 29995353 [TBL] [Abstract][Full Text] [Related]
3. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis. Chen SQ; Song YQ; Wang C; Tao S; Yu FY; Lou HY; Hu FQ; Yuan H Carbohydr Polym; 2020 Feb; 230():115613. PubMed ID: 31887935 [TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment. Huang P; Wang G; Su Y; Zhou Y; Huang W; Zhang R; Yan D Theranostics; 2019; 9(20):5755-5768. PubMed ID: 31534517 [TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520 [TBL] [Abstract][Full Text] [Related]
6. Facile synthesis of multifunctional germanium nanoparticles as a carrier of quercetin to achieve enhanced biological activity. Guo YJ; Yang F; Zhang L; Pi J; Cai JY; Yang PH Chem Asian J; 2014 Aug; 9(8):2272-80. PubMed ID: 24958675 [TBL] [Abstract][Full Text] [Related]
7. Reducing Interstitial Fluid Pressure and Inhibiting Pulmonary Metastasis of Breast Cancer by Gelatin Modified Cationic Lipid Nanoparticles. Gao X; Zhang J; Huang Z; Zuo T; Lu Q; Wu G; Shen Q ACS Appl Mater Interfaces; 2017 Sep; 9(35):29457-29468. PubMed ID: 28799743 [TBL] [Abstract][Full Text] [Related]
8. Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer. Jiang M; Zhang R; Wang Y; Jing W; Liu Y; Ma Y; Sun B; Wang M; Chen P; Liu H; He Z Mol Pharm; 2017 Nov; 14(11):3628-3635. PubMed ID: 28895735 [TBL] [Abstract][Full Text] [Related]
9. Lipid-based nanocarrier for quercetin delivery: system characterization and molecular interactions studies. Hädrich G; Monteiro SO; Rodrigues MR; de Lima VR; Putaux JL; Bidone J; Teixeira HF; Muccillo-Baisch AL; Dora CL Drug Dev Ind Pharm; 2016; 42(7):1165-73. PubMed ID: 26571009 [TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy. Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855 [TBL] [Abstract][Full Text] [Related]
11. Quercetin induces protective autophagy and apoptosis through ER stress via the p-STAT3/Bcl-2 axis in ovarian cancer. Liu Y; Gong W; Yang ZY; Zhou XS; Gong C; Zhang TR; Wei X; Ma D; Ye F; Gao QL Apoptosis; 2017 Apr; 22(4):544-557. PubMed ID: 28188387 [TBL] [Abstract][Full Text] [Related]
12. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597 [TBL] [Abstract][Full Text] [Related]
13. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Gao X; Wang B; Wei X; Men K; Zheng F; Zhou Y; Zheng Y; Gou M; Huang M; Guo G; Huang N; Qian Z; Wei Y Nanoscale; 2012 Nov; 4(22):7021-30. PubMed ID: 23044718 [TBL] [Abstract][Full Text] [Related]
14. Construction of quercetin-fucoidan nanoparticles and their application in cancer chemo-immunotherapy treatment. Lin Z; Liu Y; Gong X; Nie F; Xu J; Guo Y Int J Biol Macromol; 2024 Jan; 256(Pt 1):128057. PubMed ID: 37956805 [TBL] [Abstract][Full Text] [Related]
15. Reappraisal of the anticancer efficacy of quercetin in oral cancer cells. Chen SF; Nien S; Wu CH; Liu CL; Chang YC; Lin YS J Chin Med Assoc; 2013 Mar; 76(3):146-52. PubMed ID: 23497967 [TBL] [Abstract][Full Text] [Related]
16. Oral Delivery of a High Quercetin Payload Nanosized Emulsion: In Vitro and In Vivo Activity Against B16-F10 Melanoma. Dora CL; Silva LF; Mazzarino L; Siqueira JM; Fernandes D; Pacheco LK; Maioral MF; Santos-Silva MC; Baischl AL; Assreuy J; Lemos-Senna E J Nanosci Nanotechnol; 2016 Feb; 16(2):1275-81. PubMed ID: 27433577 [TBL] [Abstract][Full Text] [Related]
17. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845 [TBL] [Abstract][Full Text] [Related]
18. Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor. Feng C; Li J; Mu Y; Kong M; Li Y; Raja MA; Cheng XJ; Liu Y; Chen XG Int J Biol Macromol; 2017 Jan; 94(Pt A):170-180. PubMed ID: 27720963 [TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer. Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938 [TBL] [Abstract][Full Text] [Related]
20. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery. Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]